Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site)

FDA inspection history in Dezhou, China, 2023

1
Form 483

Every document, by year

  • Form 483

2023: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2023One Form 483, at Dezhou, China.

Cited most

Across all Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site) observations on file

The complete Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site) file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2023-01-13483 Form 483$99

Investigators on these documents

Tonia Barnard (1)

FEI number 3023338181 · most recent document Jan 13, 2023

About Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site)

How many FDA Form 483s has Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site) received?

FDA Intel has 1 Form 483 on file for Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site); the most recent is dated Jan 13, 2023.

When was Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site) last inspected by FDA?

The most recent FDA inspection document on file for Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site) is a Form 483 dated Jan 13, 2023, for the site in Dezhou, China.

What did FDA cite at Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site)?

The regulations cited most in the observations on file for Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site) are 21 CFR 211.67 (Equipment cleaning and maintenance), 1 time.